Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study

Drug Design Development and Therapy ◽

10.2147/dddt.s86168 ◽

2015 ◽

pp. 2911 ◽

Author(s):

Kyun-Seop Bae ◽

Hee Youn Choi ◽

Yook-Hwan Noh ◽

Shi Hyang Lee ◽

Hyeong-Seok Lim ◽

...

Keyword(s):

Single Dose ◽

Sustained Release ◽

Dose Proportionality ◽

Incomplete Block ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

An open-label, randomized, single-dose, dose-proportionality study of oral doses of a sustained-release formulation of desvenlafaxine succinate in healthy subjects

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2004.12.207 ◽

2005 ◽

Vol 77 (2) ◽

pp. P82-P82 ◽

Author(s):

J BEHRLE ◽

A NICHOLS ◽

S MCGRORY ◽

D RAIBLE

Keyword(s):

Single Dose ◽

Sustained Release ◽

Healthy Subjects ◽

Dose Proportionality ◽

Release Formulation ◽

Sustained Release Formulation ◽

Download Full-text

Single Dose Crossover Study to Evaluate the Absolute Bioavailability of a Sustained-Release Formulation of Bunazosin (E1015) in Healthy Male Volunteers

Drug Investigation ◽

10.1007/bf03259419 ◽

1993 ◽

Vol 6 (1) ◽

pp. 5-9

Author(s):

Nobumichi Morishita ◽

Yoshiro Tomono ◽

Jiro Hasegawa ◽

Horst-Jürgen Heuer

Keyword(s):

Single Dose ◽

Sustained Release ◽

Crossover Study ◽

Absolute Bioavailability ◽

Healthy Male ◽

Release Formulation ◽

Sustained Release Formulation ◽

Healthy Male Volunteers ◽

Male Volunteers ◽

Download Full-text

Bioavailability of a sustained release formulation of acipimox, following a single dose in healthy volunteers in fasting and fed conditions

European Journal of Pharmacology ◽

10.1016/0014-2999(90)93269-v ◽

1990 ◽

Vol 183 (2) ◽

pp. 391 ◽

Author(s):

C. Efthymiopoulos ◽

M. Strolin Benedetti ◽

F. Ruff ◽

C. Advenier ◽

L. Musatti

Keyword(s):

Single Dose ◽

Sustained Release ◽

Healthy Volunteers ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Development of Denticap, a Matrix Based Sustained Release Formulation for Treatment of Toothache, Dental Infection and Other Gum Problem

Current Drug Delivery ◽

10.2174/156720109787846270 ◽

2009 ◽

Vol 6 (2) ◽

pp. 199-207 ◽

Author(s):

Biswajit Mukherjee ◽

Gopa Roy ◽

Soma Ghosh

Keyword(s):

Sustained Release ◽

Dental Infection ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Plasma Levels and Negative Chronotropic Effect of Metoprolol following Single Doses of a Conventional and Sustained Release Formulation C. P. Quarterman, M. J. Kendall, R. G. Welling vol. 15, 97?103 (1979)

European Journal of Clinical Pharmacology ◽

10.1007/bf00562065 ◽

1979 ◽

Vol 16 (3) ◽

pp. 219-219

Author(s):

D. A. Piercy ◽

C. P. Quarterman ◽

M. J. Kendall ◽

P. G. Welling

Keyword(s):

Sustained Release ◽

Plasma Levels ◽

Chronotropic Effect ◽

Release Formulation ◽

Sustained Release Formulation ◽

Negative Chronotropic Effect

Download Full-text

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite

Chemistry Central Journal ◽

10.1186/1752-153x-7-72 ◽

2013 ◽

Vol 7 (1) ◽

Author(s):

Bullo Saifullah ◽

Mohd Zobir Hussein ◽

Samer Hasan Hussein-Al-Ali ◽

Palanisamy Arulselvan ◽

Sharida Fakurazi

Keyword(s):

Salicylic Acid ◽

Sustained Release ◽

Release Formulation ◽

Sustained Release Formulation ◽

Amino Salicylic Acid ◽

Zinc Layered Hydroxide

Download Full-text

P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(12)60124-5 ◽

2012 ◽

Vol 22 ◽

pp. S48

Author(s):

P. Saenger ◽

V. Khadilkar ◽

K.A. Radjuk ◽

E. Bolshova ◽

R. Khadgawat ◽

...

Keyword(s):

Sustained Release ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration of a sustained release formulation to healthy volunteers

International Journal of Pharmaceutics ◽

10.1016/0378-5173(93)90399-z ◽

1993 ◽

Vol 95 (1-3) ◽

pp. 127-133

Author(s):

C. Efthymiopoulos ◽

D.M.F. Edwards ◽

M. Strolin-Benedetti ◽

F. Ruff ◽

C. Advenier ◽

...

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Healthy Volunteers ◽

Release Formulation ◽

Sustained Release Formulation

Download Full-text

Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure

European Journal of Clinical Pharmacology ◽

10.1007/bf00542156 ◽

1984 ◽

Vol 27 (3) ◽

pp. 259-263 ◽

Author(s):

O. Dubourg ◽

P. Gueret ◽

A. Ferrier ◽

J. C. Farcot ◽

M. Terdjman ◽

...

Keyword(s):

Sustained Release ◽

Isosorbide Dinitrate ◽

Left Ventricular ◽

Left Ventricular Failure ◽

Ventricular Failure ◽

Release Formulation ◽

Sustained Release Formulation ◽

Haemodynamic Study

Download Full-text

▾ Piretanide for hypertension

Drug and Therapeutics Bulletin ◽

10.1136/dtb.23.11.43 ◽

1985 ◽

Vol 23 (11) ◽

pp. 43-44

Keyword(s):

Glucose Tolerance ◽

Sustained Release ◽

Loop Diuretic ◽

Plasma Potassium ◽

Release Formulation ◽

Sustained Release Formulation ◽

Treatment Of Hypertension

Piretanide is a loop diuretic recently marketed in a sustained-release formulation (Arelix - Hoechst) solely for the treatment of hypertension (rather than as a general diuretic). The manufacturer claims that piretanide has several advantages over the thiazides, including little or no effect on plasma potassium and magnesium, and no impairment of glucose tolerance.

Download Full-text